Ananda Developments Plc (AQSE: ANA), a developer of cannabinoid medicines, has secured the necessary funding to initiate a trial to test the effectiveness of its cannabidiol oil, MRX1, in treating
Ananda Developments (AQSE:ANA) First Cannabinoid Medicines Launched
Ananda’s ambition is to be a leading provider of high-quality cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.
Company Profile (AQSE:ANA) Ananda Developments
Ananda Developments (AQSE: ANA) is an AQUIS-listed healthcare company involved in the development of cannabinoid-based medicines with two concurrently running, third-party funded, Phase II randomised control trials (RCTs).
Zak Mir talks to Melissa Sturgess, CEO Ananda Developments
In the wake of the MRX Global acquisition, and what this means for the medical cannabis group
Light Science Tech. (AIM:LST) Trading Update
Light Science Technologies Holdings plc (AIM: LST), the controlled environment agriculture (“CEA”) technology and contract electronics manufacturing (“CEM”) group, provides an update on current trading.
FastForward Inn Ltd (FFWD.L) Investment in cannabis healthcare company- CiiTECH
FastForward Innovations Ltd, (AIM:FFWD) the listed investor focused on fast-growing and industry leading businesses, is pleased to announce that it has participated in the £2.1 million issuance of Convertible Loan
FastForward Inn Ltd (FFWD.L) Investee Company Update: Little Green Pharma Ltd
FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to note the announcement by portfolio company Little Green Pharma
FastForward Inn Ltd (FFWD.L) Investee Company Update: Little Green Pharma
FastForward Innovations Ltd, the AIM-quoted company focusing on making investments in fast-growing and industry-leading businesses, is pleased to note that Little Green Pharma Ltd (‘LGP’) has announced an additional A$2.5m
Ananda Developments Plc (ANA.L) Grant of Home Office Licence
The Directors of Ananda announce the following progress regarding Ananda’s vision to become a significant participant in the emerging medicinal cannabis sector:
Stephen Murphy Co-Founder, CEO of Prohibition Partners Interview
Prohibition Partners unlocks the potential of cannabis through data, intelligence and networking. They provide strategic solutions to an international client base of investors, operators, blue-chip companies, FMCG brands and government
UK-based Eco Equity approved for medicinal cannabis license in Antigua and Barbuda
London: London-based medicinal cannabis company has been approved, pending ratification from the licensing Board for a medicinal cannabis Dispensary licence in Antigua and Barbuda.